119 related articles for article (PubMed ID: 29411975)
1. Affinity-Based Screen for Inhibitors of Bacterial Transglycosylase.
Wu WS; Cheng WC; Cheng TR; Wong CH
J Am Chem Soc; 2018 Feb; 140(8):2752-2755. PubMed ID: 29411975
[TBL] [Abstract][Full Text] [Related]
2. Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Tseng YY; Liou JM; Hsu TL; Cheng WC; Wu MS; Wong CH
Bioorg Med Chem Lett; 2014 Jun; 24(11):2412-4. PubMed ID: 24775303
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of bacterial transglycosylase inhibitors incorporating biphenyl, amine linker and 2-alkoxy-3-phosphorylpropanoate moieties.
Yu JY; Cheng HJ; Wu HR; Wu WS; Lu JW; Cheng TJ; Wu YT; Fang JM
Eur J Med Chem; 2018 Apr; 150():729-741. PubMed ID: 29574202
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase.
Baizman ER; Branstrom AA; Longley CB; Allanson N; Sofia MJ; Gange D; Goldman RC
Microbiology (Reading); 2000 Dec; 146 Pt 12():3129-3140. PubMed ID: 11101671
[TBL] [Abstract][Full Text] [Related]
5. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
[TBL] [Abstract][Full Text] [Related]
6. Towards new antibiotics targeting bacterial transglycosylase: Synthesis of a Lipid II analog as stable transition-state mimic inhibitor.
Wang X; Krasnova L; Wu KB; Wu WS; Cheng TJ; Wong CH
Bioorg Med Chem Lett; 2018 Sep; 28(16):2708-2712. PubMed ID: 29602680
[TBL] [Abstract][Full Text] [Related]
7. Some selective reactions of moenomycin A.
Vogel S; Buchynskyy A; Stembera K; Richter K; Hennig L; Müller D; Welzel P; Maquin F; Bonhomme C; Lampilas M
Bioorg Med Chem Lett; 2000 Sep; 10(17):1963-5. PubMed ID: 10987427
[TBL] [Abstract][Full Text] [Related]
8. A surface plasmon resonance analysis of the interaction between the antibiotic moenomycin A and penicillin-binding protein 1b.
Stembera K; Vogel S; Buchynskyy A; Ayala JA; Welzel P
Chembiochem; 2002 Jun; 3(6):559-65. PubMed ID: 12325012
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design, synthesis, and biological evaluation of isatin derivatives as potential glycosyltransferase inhibitors.
Wang Y; Chan FY; Sun N; Lui HK; So PK; Yan SC; Chan KF; Chiou J; Chen S; Abagyan R; Leung YC; Wong KY
Chem Biol Drug Des; 2014 Dec; 84(6):685-96. PubMed ID: 24890564
[TBL] [Abstract][Full Text] [Related]
10. Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors.
Gampe CM; Tsukamoto H; Doud EH; Walker S; Kahne D
J Am Chem Soc; 2013 Mar; 135(10):3776-9. PubMed ID: 23448584
[TBL] [Abstract][Full Text] [Related]
11. High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
Cheng TJ; Wu YT; Yang ST; Lo KH; Chen SK; Chen YH; Huang WI; Yuan CH; Guo CW; Huang LY; Chen KT; Shih HW; Cheng YS; Cheng WC; Wong CH
Bioorg Med Chem; 2010 Dec; 18(24):8512-29. PubMed ID: 21075637
[TBL] [Abstract][Full Text] [Related]
12. Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase.
Singh SB
Bioorg Med Chem; 2016 Dec; 24(24):6291-6297. PubMed ID: 27143131
[TBL] [Abstract][Full Text] [Related]
13. Functional and structural analysis of a key region of the cell wall inhibitor moenomycin.
Fuse S; Tsukamoto H; Yuan Y; Wang TS; Zhang Y; Bolla M; Walker S; Sliz P; Kahne D
ACS Chem Biol; 2010 Jul; 5(7):701-11. PubMed ID: 20496948
[TBL] [Abstract][Full Text] [Related]
14. Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel.
Hlasta DJ; Demers JP; Foleno BD; Fraga-Spano SA; Guan J; Hilliard JJ; Macielag MJ; Ohemeng KA; Sheppard CM; Sui Z; Webb GC; Weidner-Wells MA; Werblood H; Barrett JF
Bioorg Med Chem Lett; 1998 Jul; 8(14):1923-8. PubMed ID: 9873460
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 1,2,5-oxadiazoles and evaluation of action against Acinetobacter baumannii.
Christoff RM; Murray GL; Kostoulias XP; Peleg AY; Abbott BM
Bioorg Med Chem; 2017 Dec; 25(24):6267-6272. PubMed ID: 29032931
[TBL] [Abstract][Full Text] [Related]
16. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
17. Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
Krátký M; Vinšová J
Bioorg Med Chem; 2016 Mar; 24(6):1322-30. PubMed ID: 26879856
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Hydrazone Derivatives of 4-[4-Formyl-3-(2-oxochromen-3-yl)pyrazol-1-yl]benzoic acid as Potent Growth Inhibitors of Antibiotic-resistant
Whitt J; Duke C; Sumlin A; Chambers SA; Alnufaie R; Gilmore D; Fite T; Basnakian AG; Alam MA
Molecules; 2019 May; 24(11):. PubMed ID: 31146470
[TBL] [Abstract][Full Text] [Related]
19. The molecular biology of moenomycins: towards novel antibiotics based on inhibition of bacterial peptidoglycan glycosyltransferases.
Ostash B; Doud E; Fedorenko V
Biol Chem; 2010 May; 391(5):499-504. PubMed ID: 20302515
[TBL] [Abstract][Full Text] [Related]
20. Determination of antibacterial activity and minimum inhibitory concentration of larval extract of fly via resazurin-based turbidometric assay.
Teh CH; Nazni WA; Nurulhusna AH; Norazah A; Lee HL
BMC Microbiol; 2017 Feb; 17(1):36. PubMed ID: 28209130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
